Stock GNPX GENPREX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Genprex, Inc.

Equities

GNPX

US3724462037

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
2.21 USD +4.25% Intraday chart for Genprex, Inc. +3.76% -75.98%
Apr. 03 Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer CI
Apr. 02 Genprex, Inc. Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. GNPX Stock
  4. Revisions Genprex, Inc.